logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 12136472 B1

PDFFull Text
Date of Patent:
Nov. 05, 2024

Filed:

Sep. 14, 2023

Molecular evidence platform for auditable, continuous optimization of variant interpretation in genetic and genomic testing and analysis

Applicant:

Laboratory Corporation of America Holdings, Burlington, NC (US);

Inventors:

Alexandre Colavin, Menlo Park, CA (US);

Carlos L. Araya, Palo Alto, CA (US);

Jason A. Reuter, Palo Alto, CA (US);

Assignee:

Laboratory Corporation of America Holdings, Burlington, NC (US);

Attorney:

Sterne, Kessler, Goldstein & Fox P.L.L.C.

Primary Examiner:

Manav Seth

Int. Cl.
CPC ...
G16B 20/20 (2019.01); G06F 18/21 (2023.01); G06F 18/2113 (2023.01); G06N 20/00 (2019.01); G16B 5/00 (2019.01); G16B 20/00 (2019.01); G16B 30/00 (2019.01); G16B 40/00 (2019.01); G16B 50/00 (2019.01); G16B 50/10 (2019.01); H04L 9/06 (2006.01); H04L 67/10 (2022.01); H04L 9/00 (2022.01);
U.S. Cl.
CPC ...
G16B 20/20 (2019.02); G06F 18/2113 (2023.01); G06F 18/217 (2023.01); G06N 20/00 (2019.01); G16B 5/00 (2019.02); G16B 20/00 (2019.02); G16B 30/00 (2019.02); G16B 40/00 (2019.02); G16B 50/00 (2019.02); G16B 50/10 (2019.02); H04L 9/0637 (2013.01); H04L 9/0643 (2013.01); H04L 67/10 (2013.01); H04L 9/50 (2022.05);
Abstract

Disclosed herein are system, method, and computer program product embodiments for optimizing the determination of a phenotypic impact of a molecular variant identified in molecular tests, samples, or reports of subjects by way of regularly incorporating, updating, monitoring, validating, selecting, and auditing the best-performing evidence models for the interpretation of molecular variants across a plurality of evidence classes.

Find Patent Forward Citations

Colavin, Alexandre. (2024). Molecular evidence platform for auditable, continuous optimization of variant interpretation in genetic and genomic testing and analysis (U.S. Patent No. 12136472). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/12136472

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…